MAGE-A3 TCR-T

N/A

Report date: 2025/03/20 15:47:18

Base Information

Drug NameMAGE-A3 TCR-T
Drug Alias Nameanti-MAGE-A3 TCR T-cell therapy (China Immunotech)
ClassificationBiologics > Protein drugs > Recombinant proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionMelanoma-associated antigen 3 modulatorsHuman leukocyte antigen modulators
TargetsMelanoma-associated antigen 3Human leukocyte antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Immunotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina Immunotech Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A